103 related articles for article (PubMed ID: 1983629)
1. [Responsibilities of biostatistics for evaluation of treatment results in tumor therapy].
Guggenmoos-Holzmann I
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():65-8. PubMed ID: 1983629
[TBL] [Abstract][Full Text] [Related]
2. From randomized trials to registry studies: translating data into clinical information.
Brown ML; Gersh BJ; Holmes DR; Bailey KR; Sundt TM
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):613-20. PubMed ID: 18679381
[TBL] [Abstract][Full Text] [Related]
3. Randomized trials or population-based registries.
Bergqvist D; Björck M; Säwe J; Troëng T
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):253-6. PubMed ID: 17689818
[No Abstract] [Full Text] [Related]
4. Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial.
Putter H; Sasako M; Hartgrink HH; van de Velde CJ; van Houwelingen JC
Stat Med; 2005 Sep; 24(18):2807-21. PubMed ID: 16134134
[TBL] [Abstract][Full Text] [Related]
5. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic.
Chang MN; Shuster JJ
Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402
[TBL] [Abstract][Full Text] [Related]
6. Intention-to-treat analyses for incomplete repeated measures data.
Hogan JW; Laird NM
Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
[TBL] [Abstract][Full Text] [Related]
7. [Data management for clinical trials at the data center].
Niimi M; Fukuda H; Yamamoto S; Okuyama S; Yamaguchi N
Gan To Kagaku Ryoho; 1998 Jan; 25(2):253-9. PubMed ID: 9474934
[TBL] [Abstract][Full Text] [Related]
8. [Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint].
Müller HH; Schäfer H
Zentralbl Chir; 1995; 120(10):755-9. PubMed ID: 7502588
[TBL] [Abstract][Full Text] [Related]
9. On the choice of times for data analysis in group sequential clinical trials.
Li ZH; Geller NL
Biometrics; 1991 Jun; 47(2):745-50. PubMed ID: 1912268
[TBL] [Abstract][Full Text] [Related]
10. Application of the principal stratification approach to the Faenza randomized experiment on breast self-examination.
Mattei A; Mealli F
Biometrics; 2007 Jun; 63(2):437-46. PubMed ID: 17688496
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of population-based cancer survival data.
Black RJ; Sankaranarayanan R; Parkin DM
IARC Sci Publ; 1998; (145):13-7. PubMed ID: 10194623
[No Abstract] [Full Text] [Related]
12. Strength of accumulating evidence and data monitoring committee decision making.
George SL; Freidlin B; Korn EL
Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
[TBL] [Abstract][Full Text] [Related]
13. Regarding paper "Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance" by Lui K. J. and Chang K. C.
Vach W
Biom J; 2007 Aug; 49(4):627-9; author reply 630-1. PubMed ID: 17722194
[No Abstract] [Full Text] [Related]
14. On the design and analysis of randomized clinical trials with multiple endpoints.
Tang DI; Geller NL; Pocock SJ
Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
[TBL] [Abstract][Full Text] [Related]
15. Case-only analysis of treatment-covariate interactions in clinical trials.
Vittinghoff E; Bauer DC
Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319
[TBL] [Abstract][Full Text] [Related]
16. Bayesian extrapolation of space-time trends in cancer registry data.
Schmid V; Held L
Biometrics; 2004 Dec; 60(4):1034-42. PubMed ID: 15606424
[TBL] [Abstract][Full Text] [Related]
17. [Methodological aspects of biostatistics and epidemiology in a clinical trial].
Suárez E; Pérez CM
P R Health Sci J; 1999 Mar; 18(1):23-30. PubMed ID: 10343983
[TBL] [Abstract][Full Text] [Related]
18. [CONSORT--what a proper scientific publication should supply].
Windeler J; Koch A
Med Klin (Munich); 2000 May; 95(1 Spec No):91-7. PubMed ID: 10851855
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the clinical cancer register to internal quality assurance in surgical oncology].
Altendorf-Hofmann A; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():159-61. PubMed ID: 9101818
[TBL] [Abstract][Full Text] [Related]
20. A method for sequential analysis of survival data with nonproportional hazards.
Sooriyarachchi MR; Whitehead J
Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
